reviews of glp 1 A new review by Clifford J. Rosen, MD, and Julie R. Ingelfinger, MD, describes a new generation treatment with GLP-1 receptor agonists for persons with obesity with or without diabetes or GLP-1 and weight loss injections

Since the first-line intervention for obesity is typically lifestyle change(s) 4 , this study purposefully combined LD switch with 5A-1MQ treatment

A Review on Prevalence and Causes of Peripheral Neuropathy and Treatment of Different Etiologic Subgroups with Neurotropic B Vitamins

This is especially true for drugs that can act on several processes in the body, even if there is only one primary target

Unlike older weight loss medications, tirzepatide's dual-receptor approach produces sustained weight reduction in clinical trials, with patients losing 20-25% of body weight over 68 weeks

The relationship between thyroid function and weight management medications requires careful clinical consideration

R-YG: project administration